WGS GeneDx Holdings Corp revenue, earnings and financials
For the quarter ended June 30, 2026, GeneDx Holdings Corp reported revenue of $114M (up 11.4% from a year earlier), net income of −$17.7M and diluted EPS of −$0.60; over the last four quarters revenue was $454M and net income −$106M; for the fiscal year ended December 2025 revenue was $428M, up 40.0% on the year before.
WGS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $428M, gross profit $298M, operating income −$13.1M, net income −$21.0M (margin -4.9%), EPS −$0.73
- Fiscal year ended Dec 2024: revenue $305M, gross profit $194M, operating income −$23.2M, net income −$52.3M (margin -17.1%), EPS −$1.94
- Fiscal year ended Dec 2023: revenue $203M, gross profit $90.0M, operating income −$181M, net income −$176M (margin -86.8%), EPS −$7.23
- Fiscal year ended Dec 2022: revenue $235M, gross profit −$26.8M, operating income −$668M, net income −$549M (margin -233.9%), EPS −$53.63
- Fiscal year ended Dec 2021: revenue $212M, gross profit −$16.6M, operating income −$446M, net income −$245M (margin -115.6%), EPS −$2.27
WGS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $114M (up 11.4% year over year), net income −$17.7M, EPS −$0.60
- Quarter ended Mar 31, 2026: revenue $102M (up 17.4% year over year), net income −$63.3M, EPS −$2.16
- Quarter ended Dec 31, 2025 (from the annual report): revenue $121M (up 26.5% year over year), net income −$17.6M, EPS −$0.59
- Quarter ended Sep 30, 2025: revenue $117M (up 51.9% year over year), net income −$7.64M, EPS −$0.27
- Quarter ended Jun 30, 2025: revenue $103M (up 45.6% year over year), net income $10.8M, EPS $0.36
- Quarter ended Mar 31, 2025: revenue $87.1M (up 39.6% year over year), net income −$6.53M, EPS −$0.23
- Quarter ended Dec 31, 2024 (from the annual report): revenue $95.6M (up 66.6% year over year), net income $5.42M, EPS $0.25
- Quarter ended Sep 30, 2024: revenue $76.9M (up 44.2% year over year), net income −$8.31M, EPS −$0.31
- Quarter ended Jun 30, 2024: revenue $70.5M (up 44.8% year over year), net income −$29.2M, EPS −$1.10
- Quarter ended Mar 31, 2024: revenue $62.4M (up 44.7% year over year), net income −$20.2M, EPS −$0.78
- Quarter ended Dec 31, 2023 (from the annual report): revenue $57.4M (down 6.4% year over year), net income −$25.8M, EPS −$0.71
- Quarter ended Sep 30, 2023: revenue $53.3M (down 36.0% year over year), net income −$42.3M, EPS −$1.64
- Quarter ended Jun 30, 2023: revenue $48.7M (up 34.7% year over year), net income −$46.7M, EPS −$1.84
- Quarter ended Mar 31, 2023: revenue $43.1M (down 20.0% year over year), net income −$61.0M, EPS −$3.04
- Quarter ended Dec 31, 2022 (from the annual report): revenue $61.4M (up 6.1% year over year), net income −$309M, EPS −$28.15
- Quarter ended Sep 30, 2022: revenue $83.2M (up 92.8% year over year), net income −$77.6M, EPS −$6.72
- Quarter ended Jun 30, 2022: revenue $36.2M (down 23.1% year over year), net income −$85.7M, EPS −$8.38
- Quarter ended Mar 31, 2022: revenue $53.9M (down 16.0% year over year), net income −$76.9M, EPS −$10.38
- Quarter ended Dec 31, 2021: revenue $57.8M, net income −$40.2M, EPS $388.33
- Quarter ended Sep 30, 2021: revenue $43.2M, net income $32.7M, EPS $0.16
WGS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $33.3M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$28.5M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$180M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$319M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$190M, share buybacks n/a
WGS balance sheet
- Jun 30, 2026: cash $60.3M, total assets $481M, total liabilities $237M, shareholders' equity $244M, long-term debt $96.8M
- Mar 31, 2026: cash $93.9M, total assets $506M, total liabilities $252M, shareholders' equity $254M, long-term debt $96.7M
- Dec 31, 2025: cash $105M, total assets $524M, total liabilities $216M, shareholders' equity $308M, long-term debt $48.2M
- Sep 30, 2025: cash $96.0M, total assets $494M, total liabilities $202M, shareholders' equity $292M, long-term debt $51.6M
- Jun 30, 2025: cash $74.1M, total assets $464M, total liabilities $187M, shareholders' equity $277M, long-term debt $51.7M
- Mar 31, 2025: cash $99.7M, total assets $446M, total liabilities $189M, shareholders' equity $257M, long-term debt $51.8M
- Dec 31, 2024: cash $85.2M, total assets $419M, total liabilities $174M, shareholders' equity $245M, long-term debt $51.9M
- Sep 30, 2024: cash $57.9M, total assets $409M, total liabilities $204M, shareholders' equity $205M, long-term debt $52.0M
What is WGS's revenue?
GeneDx Holdings Corp reported $454M of revenue over its last four quarters, through June 30, 2026.
Is WGS profitable?
No. GeneDx Holdings Corp lost $106M over the last four quarters.
What is WGS's EPS?
Diluted earnings per share over the last four quarters were −$3.62; −$0.60 in the latest quarter.